Solta Medical, Inc. to Participate in 2nd Annual Lazard Capital Markets Medical Technology Conference

HAYWARD, Calif., Feb. 23 /PRNewswire-FirstCall/ -- Solta Medical, Inc. , a global leader in the medical aesthetics market, today announced that Clint Carnell, Chief Operating Officer, will participate in Lazard Capital Markets’ 2nd Annual Medical Technology Conference this Thursday, February 25, 2010 at the Cliff Lodge in Snowbird, Utah.

About Solta Medical, Inc.

The company offers products to address aging skin under the industry’s two premier brands: Thermage(R) and Fraxel(R). Thermage is an innovative, non-invasive radiofrequency procedure for tightening and contouring skin. As the leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin. Since 2002, over one million Thermage and Fraxel procedures have been performed in nearly 80 countries. Thermage and Fraxel are the perfect complement for any aesthetic practice. For more information about Solta Medical, call 1-877-782-2286 or log on to www.Solta.com.

CONTACT: Jack Glenn, Chief Financial Officer of Solta Medical, Inc.,
+1-510-786-6890

Web site: http://www.Solta.com/

MORE ON THIS TOPIC